Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2018 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Unresectable Oropharyngeal Squamous Cell Carcinoma"
Page 1
p16(INK4a) status and survival benefit of EGFR inhibitors in head and neck squamous cell cancer: A systematic review and meta-analysis.
Su Y, Cui J, Xu D, Wang M, Xu T, Tian H, Han F. Su Y, et al. Crit Rev Oncol Hematol. 2018 Apr;124:11-20. doi: 10.1016/j.critrevonc.2018.02.006. Epub 2018 Feb 7. Crit Rev Oncol Hematol. 2018. PMID: 29548481 Review.
BACKGROUND: We conducted a systematic review and meta-analysis to investigate the impact of p16(INK4a) status on survival benefits in head and neck squamous cell cancer (HNSCC) after anti-epidermal growth factor receptor (EGFR) based treatments. METHOD …
BACKGROUND: We conducted a systematic review and meta-analysis to investigate the impact of p16(INK4a) status on survival benefits in hea …
A systematic review of antibody-drug conjugates and bispecific antibodies in head and neck squamous cell carcinoma and nasopharyngeal carcinoma: Charting the course of future therapies.
Jiménez-Labaig P, Rullan A, Hernando-Calvo A, Llop S, Bhide S, O'Leary B, Braña I, Harrington KJ. Jiménez-Labaig P, et al. Cancer Treat Rev. 2024 Jul;128:102772. doi: 10.1016/j.ctrv.2024.102772. Epub 2024 May 26. Cancer Treat Rev. 2024. PMID: 38820656
INTRODUCTION: There is a need to improve the outcomes of patients with head and neck squamous cell carcinoma (HNSCC) and nasopharyngeal carcinoma (NPC), especially in recurrent unresectable and metastatic (R/M) setting. ...
INTRODUCTION: There is a need to improve the outcomes of patients with head and neck squamous cell carcinoma …
Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.
Furness S, Glenny AM, Worthington HV, Pavitt S, Oliver R, Clarkson JE, Macluskey M, Chan KK, Conway DI; CSROC Expert Panel. Furness S, et al. Cochrane Database Syst Rev. 2010 Sep 8;(9):CD006386. doi: 10.1002/14651858.CD006386.pub2. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2011 Apr 13;(4):CD006386. doi: 10.1002/14651858.CD006386.pub3. PMID: 20824847 Free article. Updated. Review.
BACKGROUND: Oral cavity and oropharyngeal cancers are frequently described as part of a group of oral cancers or head and neck cancer. ...In patients with unresectable tumours, concomitant chemoradiotherapy showed a 22% benefit in overall survival comp …
BACKGROUND: Oral cavity and oropharyngeal cancers are frequently described as part of a group of oral cancers or head and n …
Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.
Furness S, Glenny AM, Worthington HV, Pavitt S, Oliver R, Clarkson JE, Macluskey M, Chan KK, Conway DI. Furness S, et al. Cochrane Database Syst Rev. 2011 Apr 13;(4):CD006386. doi: 10.1002/14651858.CD006386.pub3. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2021 Dec 20;12:CD006386. doi: 10.1002/14651858.CD006386.pub4. PMID: 21491393 Free article. Updated. Review.
BACKGROUND: Oral cavity and oropharyngeal cancers are frequently described as part of a group of oral cancers or head and neck cancer. ...In patients with unresectable tumours, concomitant or alternating chemoradiotherapy may prolong survival by 10 to …
BACKGROUND: Oral cavity and oropharyngeal cancers are frequently described as part of a group of oral cancers or head and n …